OakChart

Option Care Health Inc

OPCHHealthcare·Medical Care Facilities·USA·Mid·NASD·Nov 11 • 3:59 PM ET

31.70+0.05 (0.16%)
2026-11-11 23:13 CET
Market cap
4,741.17 USD m
Revenue, TTM
5,752.03 USD m
Net income, TTM
215.19 USD m
Free cash flow, TTM
279.46 USD m
EPS diluted, TTM
1.39
P/E
22.88
Compare

Price

OPCH against its 20, 50 and 200-day averages
2050200beatmiss
20.0025.0030.0032.5M65.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26OPCHclose 31.7020-day 31.4850-day 27.78200-day 26.1531.70

13.9% under the 52-week high of 36.80 on 23 Jan 2026. 52-week low 18.01 on 30 Apr 2026. Last 15 sessions, 2.2% high to low

Volume 1.37× normal · the line is the 50-bar volume average

Profile

OPCH
52-week range, 73% of the way up
18.0136.80

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

IndexRUT
Employees6528
IPOAug 15, 1996
Beta0.46
ATR, 14d0.30
Rel volume1.37
Short float4.17%
Insider own1.76%
Inst own107.60%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap4.75B
Enterprise Value5.71B
Income215.19M
Sales5.75B
Book/sh8.84
Cash/sh2.00
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees6528
IPOAug 15, 1996

Ratios

P/E22.88
Forward P/E15.29
PEG1.43
P/S0.83
P/B3.59
P/C15.88
P/FCF16.99
EV/EBITDA13.88
EV/Sales0.99
Quick Ratio1.06
Current Ratio1.54
Debt/Eq0.95
LT Debt/Eq0.93
Option/ShortYes / Yes

Earnings

EPS (ttm)1.39
EPS next Y2.07
EPS next Q0.54
EPS this Y9.33%
EPS next Y10.23%
EPS next 5Y10.72%
EPS past 3/5Y15.40% -
Sales past 3/5Y12.72% 13.25%
EPS Y/Y TTM9.94%
Sales Y/Y TTM4.01%
EPS Q/Q20.11%
Sales Q/Q4.08%
EarningsNov 04 BMO
EPS/Sales Surpr.0.12% 1.16%

Ownership

Insider Own1.76%
Insider Trans0.00%
Inst Own107.60%
Inst Trans-34.44%
ROA6.19%
ROE16.04%
ROIC8.41%
Gross Margin17.86%
Oper. Margin5.88%
Profit Margin3.74%
SMA200.70%
SMA5014.13%
SMA20021.23%
Trades-

Technical

Shs Outstand149.79M
Shs Float147.17M
Short Float4.17%
Short Ratio1.56
Short Interest6.14M
52W High36.80 -13.86%
52W Low18.01 76.01%
Volatility0.61% 0.46%
ATR (14)0.30
RSI (14)75.93
Beta0.46
Rel Volume1.37
Avg Volume3.93M
Volume5,398,685

Performance

Perf Week0.16%
Perf Month1.93%
Perf Quarter31.70%
Perf Half Y60.26%
Perf YTD-0.50%
Perf Year10.65%
Perf 3Y11.03%
Perf 5Y19.49%
Perf 10Y482.72%
Recom2.92
Target Price30.03
Prev Close31.65
Price31.70
Change %0.16%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 30, 2026DowngradeDDeutsche BankBuy → Hold$24-24.3%
Jul 17, 2026DowngradeSStephensOverweight → Equal-Weight$24-24.3%
Jun 08, 2026InitiatedGGoldmanNeutral$22-30.6%
May 01, 2026DowngradeBBofA SecuritiesBuy → Neutral$22-30.6%
Dec 11, 2025InitiatedSStephensOverweight$40+26.2%
Oct 02, 2025InitiatedTTD CowenHold$30-5.4%
Apr 30, 2025UpgradeUUBSNeutral → Buy$40+26.2%
Jan 23, 2025UpgradeJJefferiesHold → Buy$26 → $35+10.4%
Jan 13, 2025UpgradeBBofA SecuritiesNeutral → Buy$26 → $33+4.1%
Dec 05, 2024InitiatedUUBSNeutral$26-18.0%

Peers

Mkt cap
TickerCompanyMkt cap
BTSGBrightSpring Health Services Inc14.45B
GRDNGuardian Pharmacy Services Inc3.17B
AVAHAveanna Healthcare Holdings Inc2.86B
ADUSAddus HomeCare Corp2.34B
CHEChemed Corp7.17B
UNHUnitedhealth Group Inc361.04B
CICigna Group79.43B
AHCOAdaptHealth Corp1.06B
CVSCVS Health Corp114.54B
INFUInfuSystem Holdings Inc302.10M

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Robert C PateDirectorNov 10 '26Proposed Sale32.006,492207,750Nov 10 01:37 PM
Smyser CollinGC & Corporate SecretaryMay 19 '26Option Exercise0.00812075,372May 21 04:08 PM
SULLIVAN TIMOTHY PDirectorMay 07 '26Buy20.6924,154499,67173,383May 07 05:04 PM
KRAEMER HARRY M JANSEN JRDirectorMay 04 '26Buy21.4136,610783,773450,000May 05 05:32 PM
Sethna MeenalChief Financial OfficerMay 04 '26Buy20.1616,225327,07598,337May 04 05:42 PM
RADEMACHER JOHN CHARLESChief Executive OfficerMay 04 '26Buy21.1812,500264,706695,152May 04 05:41 PM
Pate R CarterDirectorFeb 27 '26Sale32.0530,287970,62011,623Mar 03 04:54 PM
Bavaro MichaelChief Human Resources OfficerFeb 27 '26Sale33.006,000198,00033,249Mar 03 04:53 PM
Michael L BavaroOfficerFeb 27 '26Proposed Sale33.006,000198,000Feb 27 04:09 PM
Pate R CarterDirectorFeb 26 '26Proposed Sale31.8930,287965,852Feb 26 04:49 PM
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '26Option Exercise0.0011,0870831,506Feb 24 07:16 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
IJKiShares S&P Mid-Cap 400 Growth ETFAUM: 10.46B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.90B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.4900.4890.3801,4941,47611
2026Q22026-07-290.4500.4260.3511,4421,42012
2026Q12026-04-300.4000.3710.2871,3511,39012
2025Q42026-02-240.4600.4690.3661,4651,46212
2025Q32025-10-300.4500.4300.3181,4351,4139
2025Q22025-07-300.4100.3940.3081,4161,3507
2025Q12025-04-290.4000.3380.2801,3331,2589
2024Q42025-02-260.4400.3580.3541,3461,2899
2024Q32024-10-300.4100.3060.3131,2791,2158
2024Q22024-07-310.3000.2750.3051,2271,1708
2024Q12024-04-230.2600.2260.2551,1461,1028
2023Q42024-02-220.3200.2860.3221,1241,0888
2023Q32023-10-250.3100.2900.3121,0931,0908
2023Q22023-07-270.6300.2250.6311,0691,0648
2023Q12023-05-030.2100.1820.2151,016998.867
2022Q42023-02-230.2600.2270.2601,0271,0236

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.490-0.616-0.4862,3102,093
2020FY-0.040-0.072-0.0453,0333,021
2021FY0.7700.6490.7723,4393,429
2022FY0.8300.8280.8273,9453,940
2023FY1.4801.4421.4814,3024,266
2024FY1.5801.3111.2264,9984,941
2025FY1.7201.7291.2705,6505,646
2026FY-1.881--5,772
2027FY-2.073--6,146
2028FY-2.335--6,686
2029FY-2.550--7,220
2030FY-2.790--7,785

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-089101,4981,4701,514
2026Q4S2026-11-0610101,4961,4701,514
2026Q4S2026-11-0511101,4971,4701,514
2026Q4S2026-11-0411001,4911,4471,508
2026Q4S2026-10-1411001,4901,4471,508
2026Q4S2026-10-1311011,4901,4471,508
2026Q4S2026-10-1211021,4901,4471,508
2026Q4S2026-10-0611131,4901,4471,508
2026Q4S2026-10-0512141,4871,4471,508
2026Q4S2026-09-1712141,4871,4471,508
2026Q4S2026-08-0612141,4871,4471,508
2026Q4S2026-07-3112141,4871,4471,508
2026Q4S2026-07-3012131,4891,4471,508
2026Q4S2026-07-2912121,4911,4471,508

Estimate history

EPS, annual-2.4-0.043-0.486-0.0450.7720.8271.4811.2261.2711.3855
Period201720182019202020212022202320242025TTM
EPS, quarterly0.3130.3540.280.3080.3180.3660.2870.3510.382
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual817.191939.7912310.4173032.613438.643944.7354302.3244998.2025649.5195752.03
Period201720182019202020212022202320242025TTM
Sales, quarterly1278.5461346.4181332.9721416.0851435.0161465.4461350.6541442.41493.529
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual31.907142.614176.592179.795179.926181.958174.576166.261156.858149.793
Period201720182019202020212022202320242025MRQ
Shares, quarterly170.146166.261163.744162.294160.108156.858156.988149.777149.793
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue5,752.035,649.524,998.204,302.323,944.743,438.643,032.612,310.421,939.79
Cost of Goods Sold Incl. D&A4,724.634,629.164,046.123,380.303,138.382,722.092,421.661,851.111,555.64
Gross Profit1,027.401,020.36952.08922.02806.35716.55610.95459.31384.15
Selling, General and Administrative Excl. Other689.00682.45630.25607.43566.12525.71500.20432.45345.88
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income338.40337.91321.83314.60240.23190.84110.7526.8638.27
Interest Expense59.8863.2060.5662.2254.9055.4691.1973.3946.12
Unusual Expense-6.95-3.89-11.15-52.97-1.0924.9328.1232.98-0.23
Net Income Before Taxes295.41282.90283.60358.74205.77116.49-5.24-78.19-8.77
Income Taxes80.2175.3171.7891.6555.21-23.402.83-2.27-2.65
Consolidated Net Income215.19207.59211.82267.09150.56139.90-8.08-75.92-6.12
Net Income From Continuing Operations215.19207.59211.82267.09150.56139.90-8.08-75.92-6.12
Net Income215.19207.59211.82267.09150.56139.90-8.08-75.92-6.12
EPS (Recurring)1.401.251.181.280.820.870.06-0.34-0.04
EPS (Basic, Before Extraordinaries)1.401.281.231.490.830.78-0.04-0.49-0.04
EPS (Diluted)1.391.271.231.480.830.77-0.04-0.49-0.04
EBITDA411.59408.60385.33376.80325.38274.81207.47104.4479.32
Non-Operating Income (Expense)9.944.3011.1753.4019.346.043.321.32-1.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense31.5531.5728.5524.0813.266.992.133.041.69
Price To Earnings Ratio22.8422.8419.4223.7730.5536.71---
Price To Sales Ratio0.590.920.801.411.391.500.931.011.05
Gross Margin17.8618.0619.0521.4320.4420.8420.1519.8819.80
Operating Margin5.885.986.447.316.095.553.651.161.97
Net Margin3.743.674.246.213.824.07-0.27-3.29-0.32
Shares Outstanding149.79156.86166.26174.58181.96179.93179.79176.59142.61
Market Capitalization4,741.174,741.173,948.205,967.545,473.405,115.652,920.912,634.75457.24

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,493.531,442.401,350.651,465.451,435.021,416.091,332.971,346.42
Cost of Goods Sold Incl. D&A1,226.671,192.601,103.551,201.811,178.401,163.281,085.671,094.65
Gross Profit266.85249.80247.11263.64256.61252.80247.31251.76
Selling, General and Administrative Excl. Other177.64164.66174.56172.14172.10170.09168.12164.73
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income89.2285.1472.5591.5084.5182.7179.1987.04
Interest Expense14.6115.5415.0114.7316.3916.6615.4213.40
Unusual Expense-1.73-1.52-1.71-2.002.50-2.21-2.19-2.52
Net Income Before Taxes78.9073.9961.0081.5268.9768.8663.5681.05
Income Taxes21.4720.0715.6623.0117.1518.3416.8120.92
Consolidated Net Income57.4353.9145.3458.5051.8250.5246.7460.13
Net Income From Continuing Operations57.4353.9145.3458.5051.8250.5246.7460.13
Net Income57.4353.9145.3458.5051.8250.5246.7460.13
EPS (Recurring)0.370.340.280.360.330.300.270.34
EPS (Basic, Before Extraordinaries)0.380.350.290.370.320.310.280.36
EPS (Diluted)0.380.350.290.370.320.310.280.35
EBITDA108.05103.5288.20111.82101.5699.6695.56104.51
Non-Operating Income (Expense)2.562.871.762.753.350.60-2.404.89
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.376.6210.207.368.798.456.956.73
Price To Earnings Ratio22.8416.4121.1725.3022.1225.9428.4919.42
Price To Sales Ratio0.590.570.750.900.820.991.120.79
Gross Margin17.8717.3218.3017.9917.8817.8518.5518.70
Operating Margin5.975.905.376.245.895.845.946.46
Net Margin3.853.743.363.993.613.573.514.47
Shares Outstanding149.79149.78156.99156.86160.11162.29163.74166.26
Market Capitalization4,741.173,292.884,211.585,057.234,505.315,318.505,740.333,948.20

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments232.62412.56343.85294.19119.4299.2767.0636.3944.41
Short Term Receivables511.57465.53430.16383.14338.24330.74324.42310.1785.52
Inventories471.15388.13274.00224.28183.09158.60115.8883.3438.04
Other Current Assets49.6356.4046.2492.7369.5068.4151.3137.5219.72
Total Current Assets1,264.971,322.631,094.26994.34710.26657.01558.65467.43187.69
Net Property, Plant & Equipment230.49213.90204.79180.75186.31189.94196.7093.1426.97
Total Investments and Advances27.9031.1831.0836.7420.1017.0017.0014.600.00
Long-Term Note Receivable------0.00--
Intangible Assets1,915.921,841.261,875.641,897.541,843.581,779.661,811.45852.18386.31
Deferred Tax Assets98.55104.07111.32119.45161.75125.22117.7834.36-
Other Assets16.4912.7911.273.573.633.825.740.862.12
Total Assets3,554.323,525.813,328.353,232.392,925.642,772.662,707.331,462.57603.09
Short Term Debt Incl. Current Port. of LT Debt30.7828.5624.2825.3825.0928.1429.644.151.72
Accounts Payable639.83610.78426.51378.76279.25282.91221.06187.8965.96
Other Current Liabilities158.74140.81167.52161.21155.36122.9779.3047.9637.45
Total Current Liabilities829.35780.15618.31565.35459.69434.02330.00240.00105.13
Long Term Debt1,242.571,189.421,142.131,129.641,134.391,185.881,335.49535.23478.87
Provision for Risks Charges0.000.000.000.000.000.000.000.00-
Deferred Tax Liabilities154.57151.64146.24141.60134.72128.56119.9367.84-
Other Liabilities1.440.370.009.6820.958.4715.0916.6821.77
Total Liabilities2,227.932,121.571,906.681,846.281,749.751,756.941,800.50859.74605.76
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.0082.08
Common Equity1,326.391,404.241,421.671,386.101,175.891,015.72906.83602.83-84.75
Total Shareholders Equity1,326.391,404.241,421.671,386.101,175.891,015.72906.83602.83-2.67
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,326.391,404.241,421.671,386.101,175.891,015.72906.83602.83-2.67
Total Liabilities & Stockholders Equity3,554.323,525.813,328.353,232.392,925.642,772.662,707.331,462.57603.09
Book Value Per Share8.468.458.147.626.545.655.144.23-2.66
Tangible Book Value Per Share-3.76-2.63-2.60-2.81-3.71-4.25-5.12-1.75-14.76
Full-Time Employees6,5286,0155,8095,5975,4305,1465,9032,0432,154
Price to Book Ratio3.582.774.144.094.352.772.91-3.18-4.76
Return on Assets5.866.188.144.894.91-0.29-4.61-0.59-10.46
Return on Equity15.2014.9919.0311.7512.77-0.84-17.74-2.04-335.24
Return on Invested Capital8.088.1710.425.986.06-0.37-3.39-0.54-13.48
Quick Ratio0.961.201.331.361.151.151.341.601.42
Current Ratio1.531.701.771.761.551.511.691.951.79

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income215.19207.59211.82267.09150.56139.90-8.08-75.92-6.12
Depreciation73.1970.6963.5062.2085.1583.9796.7177.5941.05
Other Funds (Non Cash)59.0171.4855.6650.6812.4326.4426.8026.3810.89
Funds from Operations362.95358.20343.64392.74297.32219.94116.6323.4442.24
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-43.04-99.75-20.25-21.45-29.78-11.377.1316.03-17.81
Cash from Operating Activities319.91258.45323.39371.30267.55208.57123.7639.4724.43
Capital Expenditures-40.45-41.31-35.61-41.87-35.36-25.63-26.88-28.29-26.28
Net Assets From Acquisitions0.00-117.250.00-12.49-87.36-85.910.00-700.17-10.73
Sale of Fixed Assets and Businesses-0.000.003.7414.670.000.000.010.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-0.88-2.53-0.86-5.890.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.540.630.00
Cash from Investing Activities-41.33-161.08-36.47-56.51-108.05-111.54-26.33-727.83-37.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-265.61-309.95-252.73-250.260.000.00118.930.000.00
Repurchase of Common Pref Stock-265.61-309.95-252.73-250.260.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00118.930.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00118.930.000.00
Issuance or Reduction of Debt, Net-6.7840.9043.50-6.0014.92-76.84-183.25722.22-4.15
Change in Long Term Debt-6.7840.9043.50-6.0014.92-76.84-183.25722.22-4.15
Issuance of Long Term Debt0.00226.0949.880.0020.92842.340.00951.031.00
Reduction of Long Term Debt-6.78-185.19-6.38-6.00-6.00-919.18-183.25-228.81-5.15
Net Financing Active Other Cash Flow-16.92-8.25-8.98-8.870.35-0.03-0.90-3.190.00
Other Financing Activities Uses-17.96-10.60-12.38-8.870.00-0.03-0.90-4.500.00
Cash from Financing Activities-289.31-277.31-218.21-265.1315.27-76.87-65.22719.02-4.15
Net Change in Cash-10.73-179.9468.7249.66174.7620.1632.2130.66-16.73
Free Cash Flow279.46217.14287.79329.43232.19182.9496.8911.18-1.85
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow12.1123.9713.9318.4523.6028.1729.21208.65-
Deferred Taxes & Investment Tax Credit-8.4412.6612.7749.19-30.371.20-4.61-3.60

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments299.09193.77177.32232.62309.82198.82
Short Term Receivables536.87550.31559.94511.57503.50515.85
Inventories408.05399.61415.69471.15415.72403.54
Other Current Assets68.0856.9142.1649.6353.7257.02
Total Current Assets1,312.091,200.591,195.111,264.971,282.771,175.23
Net Property, Plant & Equipment224.16229.76229.71230.49226.74229.81
Total Investments and Advances30.2030.2029.6027.9028.5428.23
Intangible Assets1,888.111,897.381,906.651,915.921,925.091,933.57
Deferred Tax Assets---98.55--
Other Assets21.7020.8419.0316.4916.7115.99
Total Assets3,476.273,378.783,380.103,554.323,479.843,382.83
Short Term Debt Incl. Current Port. of LT Debt29.2329.8730.8230.7830.2529.82
Accounts Payable670.68639.77545.02639.83627.87590.22
Other Current Liabilities150.62149.84153.91158.74165.78153.57
Total Current Liabilities850.53819.48729.75829.35823.91773.62
Long Term Debt1,233.311,238.211,239.351,242.571,245.951,198.88
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities65.5858.9257.88154.5750.0249.21
Other Liabilities2.372.272.051.441.311.17
Total Liabilities2,151.792,118.882,029.032,227.932,121.192,022.88
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,324.481,259.901,351.071,326.391,358.661,359.95
Total Shareholders Equity1,324.481,259.901,351.071,326.391,358.661,359.95
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,324.481,259.901,351.071,326.391,358.661,359.95
Total Liabilities & Stockholders Equity3,476.273,378.783,380.103,554.323,479.843,382.83
Book Value Per Share8.848.418.618.468.498.38
Tangible Book Value Per Share-3.76-4.26-3.54-3.76-3.54-3.53
Full-Time Employees---6,528--
Price to Book Ratio3.582.443.183.753.313.94
Return on Assets6.196.206.175.866.066.28
Return on Equity16.0416.0015.2615.2015.0215.25
Return on Invested Capital2.252.161.752.281.991.97
Quick Ratio1.060.981.070.961.051.00
Current Ratio1.541.471.641.531.561.52

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income57.4353.9145.3458.5051.8250.52
Depreciation18.8418.3815.6520.3217.0516.95
Other Funds (Non Cash)13.8515.9212.7116.5220.7317.95
Funds from Operations96.7889.2575.58101.3490.4185.69
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital15.7596.39-89.73-65.4549.034.64
Cash from Operating Activities112.53185.64-14.1535.89139.4490.33
Capital Expenditures-6.68-11.08-9.05-13.65-9.20-9.10
Net Assets From Acquisitions0.000.000.000.000.000.07
Sale of Fixed Assets and Businesses--0.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.00-0.60-0.270.00-2.530.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-6.68-11.68-9.32-13.65-11.72-9.02
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.00-153.01-17.54-95.06-62.46-52.21
Repurchase of Common Pref Stock0.00-153.01-17.54-95.06-62.46-52.21
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1.70-1.70-1.70-1.7045.85-1.63
Change in Long Term Debt-1.70-1.70-1.70-1.7045.85-1.63
Issuance of Long Term Debt0.000.000.000.00226.090.00
Reduction of Long Term Debt-1.70-1.70-1.70-1.70-180.24-1.63
Net Financing Active Other Cash Flow-0.87-0.77-12.60-2.68-0.10-0.03
Other Financing Activities Uses-0.99-1.69-12.60-2.68-0.02-0.52
Cash from Financing Activities-0.52-157.51-31.83-99.44-16.71-53.87
Net Change in Cash105.3316.45-55.30-77.20111.0027.45
Free Cash Flow105.85174.56-23.2022.25130.2481.24
Price to Free Cash Flow12.1110.5920.2323.4520.5222.11

Revenue breakdown

Services-Home Health Care Services2024: 5.00B 2025: 5.65B
United States2024: 5.00B 2025: 5.65B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.17%6.1M147.2M3.90M
2026-10-154.84%7.1M147.2M3.77M
2026-09-305.82%8.6M147.2M2.20M
2026-09-158.22%12.1M147.2M2.26M
2026-08-318.61%12.7M147.2M2.48M
2026-08-148.18%12.0M147.2M2.74M
2026-07-318.84%13.0M147.3M3.27M
2026-07-158.73%13.5M154.4M3.34M
2026-06-308.57%13.2M154.4M3.28M
2026-06-157.93%12.2M154.4M3.05M
2026-05-298.15%12.6M154.4M2.87M
2026-05-159.67%14.9M154.4M2.73M
2026-04-307.09%10.9M154.4M2.06M
2026-04-157.55%11.6M153.5M1.77M
2026-03-316.86%10.6M153.9M1.87M
2026-03-135.76%8.9M153.9M1.85M
2026-02-275.52%8.5M153.9M1.85M
2026-02-135.33%8.2M153.9M1.80M
2026-01-305.58%8.7M156.6M2.01M
2026-01-155.26%8.2M156.6M2.14M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.5017.1021.300.006.9030.000.000.991-0.0210.001
call15.0014.6018.800.005.7730.000.000.989-0.0210.001
call17.5012.1016.306.174.8431.000.000.986-0.0200.002
call20.009.6013.9010.954.13510.000.000.983-0.0200.002
call22.507.1011.4011.503.4207.000.000.978-0.0190.003
call25.004.608.905.602.76817.000.000.970-0.0190.003
call27.502.106.400.412.1542.000.000.956-0.0170.005
call30.000.152.251.500.62382.000.000.858-0.0250.011
call32.500.002.350.050.2471,1260.000.279-0.0250.017
call35.000.000.050.080.38311.000.000.060-0.0120.006
call37.500.000.050.000.5800.000.000.042-0.0140.005
call40.000.003.400.000.7890.000.000.034-0.0170.004
call42.500.000.750.050.9541.000.000.029-0.0180.003
call45.000.000.750.001.1040.000.000.026-0.0180.003
put12.500.000.050.002.7800.000.00-0.009-0.0190.001
put15.000.000.050.002.2750.000.00-0.011-0.0190.001
put17.500.000.050.001.8470.000.00-0.014-0.0180.002
put20.000.000.050.051.40959.000.00-0.018-0.0160.002
put22.500.000.050.031.1381.000.00-0.022-0.0170.003
put25.000.000.050.010.79660.000.00-0.030-0.0140.004
put27.500.000.050.050.55253.000.00-0.044-0.0140.005
put30.000.000.050.050.2464100.00-0.151-0.0200.012
put32.500.051.001.000.26610.000.00-0.721-0.0210.017
put35.001.255.504.101.7651.000.00-0.940-0.0100.006
put37.503.708.000.002.1340.000.00-0.958-0.0110.004
put40.007.1010.500.002.4510.000.00-0.966-0.0120.004
put42.509.4013.000.002.7290.000.00-0.971-0.0130.003
put45.0011.2015.500.002.9790.000.00-0.974-0.0130.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09DEFM14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-28PREM14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-28SEC
2026-10-27SCHEDULE 13G/ASEC
2026-10-06DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-06DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-068-KCurrent report2026-10-05SEC
2026-08-14SCHEDULE 13G/ASEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-084Statement of changes in beneficial ownership of securities2026-07-06SEC
2026-07-083Initial statement of beneficial ownership of securities2026-07-06SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-228-KCurrent report2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-06SCHEDULE 13G/ASEC
2026-05-054Statement of changes in beneficial ownership of securities2026-05-04SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-05-044Statement of changes in beneficial ownership of securities2026-05-04SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-051.88M400
2026-040000
2026-030000
2026-02001.17M2
2026-010000
2025-120000
2025-11987.39K100

Institutional holders

Manager% owned
BlackRock, Inc.14.08%
WELLINGTON MANAGEMENT GROUP LLP7.50%
VANGUARD PORTFOLIO MANAGEMENT LLC5.27%
FULLER & THALER ASSET MANAGEMENT, INC.4.74%
VANGUARD CAPITAL MANAGEMENT LLC4.50%
DIMENSIONAL FUND ADVISORS LP4.21%
Durable Capital Partners LP3.93%
STATE STREET CORP3.91%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP3.81%
GEODE CAPITAL MANAGEMENT, LLC2.93%

Funds

Fund% owned
American Beacon SiM High Yield Opportunities Fund17.79%
PIMCO High Yield Fund9.55%
Eaton Vance Income Fund of Boston9.04%
iShares Broad USD High Yield Corporate Bond ETF6.53%
BlackRock High Yield Portfolio4.75%
FULLERTHALER BEHAVIORAL SMALL CAP EQUITY4.56%
Shenkman Capital Short Duration High Income Fund4.32%
VANGUARD HEALTH CARE FUND4.30%
iShares Core S&P Mid-Cap ETF3.42%
BlackRock Floating Rate Income Portfolio3.22%

OakChart. OPCH. Cached 15 minutes.